AbbVie, Unilife enter into drug delivery partnership

AbbVie ($ABBV) selected Unilife ($UNIS) as its drug delivery partner. Unilife will provide exclusive access to its Finesse prefilled syringe and the LISA reusable autoinjector to the Big Pharma for delivery of its autoimmune drugs. AbbVie paid $5 million to enter into the development and supply agreement. Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion…

Everstone, a private equity firm specializing in India and Southeast Asia, has finally decided to shell out Rs 220 crore ($33 million) to obtain a 70% stake--a…